Resveratrol Ameliorates the Anxiety- and Depression-Like Behavior of Subclinical Hypothyroidism Rat: Possible Involvement of the HPT Axis, HPA Axis, and Wnt/β-Catenin Pathway

Antioxidant treatment ameliorates experimental diabetes-induced depressive-like behaviour and reduces oxidative stress in brain and pancreas

(2015) Gislaine Z. Réus et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Depressive symptoms in patients with subclinical hypothyroidism – the effect of treatment with levothyroxine: a double-blind randomized clinical trial

(2015) Laily Najafi et al.   ENDOCRINE RESEARCH

Lithium increases platelet serine-9 phosphorylated GSK-3β levels in drug-free bipolar disorder during depressive episodes

(2015) Rafael T. de Sousa et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Antidepressant effects of resveratrol in an animal model of depression

(2014) Laura L. Hurley et al.   BEHAVIOURAL BRAIN RESEARCH

Effects of Resveratrol on Memory Performance, Hippocampal Functional Connectivity, and Glucose Metabolism in Healthy Older Adults

(2014) A. V. Witte et al.   JOURNAL OF NEUROSCIENCE

Social deficits induced by peripubertal stress in rats are reversed by resveratrol

(2014) Guillaume L. Poirier et al.   JOURNAL OF PSYCHIATRIC RESEARCH

A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones

(2014) H-H Sherry Chow et al.   Journal of Translational Medicine

Influence of Levothyroxine in Augmentation Therapy for Bipolar Depression on Central Serotonergic Function

(2014) I. Uhl et al.   PHARMACOPSYCHIATRY

Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits?

(2013) Silvie Timmers et al.   Annals of the New York Academy of Sciences

Neuroprotection by Resveratrol in Diabetic Neuropathy: Concepts & Mechanisms

(2013) A. Kumar et al.   CURRENT MEDICINAL CHEMISTRY

Epigenetic regulation ofDACH1, a novel Wnt signaling component in colorectal cancer

(2013) Wenji Yan et al.   Epigenetics

Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans

(2013) Charles-Henry Cottart et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Antidepressant-like activity of resveratrol treatment in the forced swim test and tail suspension test in mice: The HPA axis, BDNF expression and phosphorylation of ERK

(2013) Zhen Wang et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Antidepressant-like effect of resveratrol: Involvement of antioxidant effect and peripheral regulation on HPA axis

(2013) Jin-Fang Ge et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Resveratrol prevents impaired cognition induced by chronic unpredictable mild stress in rats

(2013) Dexiang Liu et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Resveratrol Stimulates Cortisol Biosynthesis by Activating SIRT-Dependent Deacetylation of P450scc

(2012) Donghui Li et al.   ENDOCRINOLOGY

Antidepressant-like effect of trans-resveratrol in chronic stress model: Behavioral and neurochemical evidences

(2012) Yingcong Yu et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder

(2012) Guilherme A. Behr et al.   Oxidative Medicine and Cellular Longevity

Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects

(2011) F Pilar-Cuéllar et al.   BRITISH JOURNAL OF PHARMACOLOGY

The Roles of Neurotrophic Factor and Wnt Signaling in Depression

(2011) B Voleti et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Functional magnetic resource imaging assessment of altered brain function in hypothyroidism during working memory processing

(2011) Xiao-Song He et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Protein levels of β-catenin and activation state of glycogen synthase kinase-3β in major depression. A study with postmortem prefrontal cortex

(2011) Félicien Karege et al.   JOURNAL OF AFFECTIVE DISORDERS

Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system

(2010) Ying Xu et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Neuroprotective effects of resveratrol on ischemic injury mediated by improving brain energy metabolism and alleviating oxidative stress in rats

(2010) Hua Li et al.   NEUROPHARMACOLOGY

SIRT1 Regulates Thyroid-Stimulating Hormone Release by Enhancing PIP5Kγ Activity through Deacetylation of Specific Lysine Residues in Mammals

(2010) Sayaka Akieda-Asai et al.   PLoS One

Resveratrol Protects Mitochondria against Oxidative Stress through AMP-Activated Protein Kinase-Mediated Glycogen Synthase Kinase-3  Inhibition Downstream of Poly(ADP-ribose)polymerase-LKB1 Pathway

(2009) S. M. Shin et al.   MOLECULAR PHARMACOLOGY

Medical disorders in people with recurrent depression

(2008) Anne Farmer et al.   BRITISH JOURNAL OF PSYCHIATRY